Guardant Health
GH
#3559
Rank
A$4.62 B
Marketcap
$37.63
Share price
-1.18%
Change (1 day)
-11.90%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of June 2024 : -A$2.42 M

According to Guardant Health 's latest financial reports the company has -A$2.42 M in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$A$0.23 B163.37%
2022-12-31$A$88.43 M-90.03%
2021-12-31$A$0.88 B-49.58%
2020-12-31$A$1.75 B45.83%
2019-12-31$A$1.20 B61.94%
2018-12-31$A$0.74 B88.44%
2017-12-31$A$0.39 B257.53%
2016-12-31$A$0.11 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$1.25 B-51,961.13%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.71 B-195,024.98%๐Ÿ‡บ๐Ÿ‡ธ USA